Cas 1207516-23-1,10-fluoro-6-(3-fluoro-4-methoxybenzyl)-2,3,4,7-tetrahydro-1H-indolo[2,3-c]quinoline

1207516-23-1

Post Buying Request

Basic information

Product Name: 10-fluoro-6-(3-fluoro-4-methoxybenzyl)-2,3,4,7-tetrahydro-1H-indolo[2,3-c]quinoline
Synonyms: 10-fluoro-6-(3-fluoro-4-methoxybenzyl)-2,3,4,7-tetrahydro-1H-indolo[2,3-c]quinoline
CAS NO:1207516-23-1
Molecular Formula:
Molecular Weight: 378.421
EINECS: N/A
Product Categories: N/A
Mol File: 1207516-23-1.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 10-fluoro-6-(3-fluoro-4-methoxybenzyl)-2,3,4,7-tetrahydro-1H-indolo[2,3-c]quinoline(CAS DataBase Reference)
NIST Chemistry Reference: 10-fluoro-6-(3-fluoro-4-methoxybenzyl)-2,3,4,7-tetrahydro-1H-indolo[2,3-c]quinoline(1207516-23-1)
EPA Substance Registry System: 10-fluoro-6-(3-fluoro-4-methoxybenzyl)-2,3,4,7-tetrahydro-1H-indolo[2,3-c]quinoline(1207516-23-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1207516-23-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1207516-23-1 Suppliers

Recommended suppliersmore

1207516-23-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1207516-23-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,7,5,1 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1207516-23:
(9*1)+(8*2)+(7*0)+(6*7)+(5*5)+(4*1)+(3*6)+(2*2)+(1*3)=121
121 % 10 = 1
So 1207516-23-1 is a valid CAS Registry Number.

1207516-23-1Upstream product

1207516-23-1Downstream Products

1207516-23-1Relevant articles and documents

BENZYL-SUBSTITUTED TETRACYCLIC HETEROCYCLIC COMPOUNDS AS PDE5 INHIBITORS

-

Page/Page column 114, (2010/04/03)

The present invention pertains to Benzyl-substituted tetracyclic heterocyclic compounds, as well as the resulting pharmaceutical compositions, and their use in the treatment or prophylaxis of diseases alleviated by inhibition of type 5 phosphodiesterases. Furthermore, the present invention pertains to the methods of manufacturing these Benzyl-substituted tetracyclic heterocyclic compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1207516-23-1